Oyster point pharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Oyster point pharma Contact Number

Contact Us Oyster Point Pharma

7 hours ago Oysterpointrx.com Get All

(609) 382-9032

Contact Details. Headquarters. Oyster Point Pharma, Inc. 202 Carnegie Center, Suite 109 Princeton, New Jersey 08540 United States. General Inquiries (609) 382-9032

Website: https://oysterpointrx.com/contact-us/

Category: Contact SupportShow more

Oyster Point Pharma

6 hours ago Oysterpointrx.com Get All

9/1/2021. Oyster Point Pharma, Inc., Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Learn More

Website: https://oysterpointrx.com/

Category: Contact NumberShow more

OYSTER POINT PHARMA, INC.

5 hours ago Investors.oysterpointrx.com Get All

(609) 382-9032

Oyster Point Pharma, Inc. 202 Carnegie Center, Suite 109 Princeton, New Jersey 08540 (609) 382-9032 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Divakar Gupta Brian J. Cuneo Ryan Sansom Nathan Ajiashvili Brandon Fenn Latham & Watkins LLP Cooley LLP 140 Scott Dr.

Website: https://investors.oysterpointrx.com/static-files/4997a1f7-1eab-450d-b91d-b9502fb604a4

Category: Contact NumberShow more

Oyster Point Pharma Company Profile Office …

5 hours ago Craft.co Get All

Oyster Point Pharma has 276 Twitter Followers. The number of followers has increased 0.8% month over month and increased 15% quarter over quarter

Founded: 2015
Website: oysterpointrx.com
Type: Public

Website: https://craft.co/oyster-point-pharmaceuticals

Category: Contact NumberShow more

OYSTER POINT PHARMA, INC.

5 hours ago Investors.oysterpointrx.com Get All

(609) 382-9032

Oyster Point Pharma, Inc. 202 Carnegie Center, Suite 109 Princeton, New Jersey 08540 (609) 382-9032 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Divakar Gupta Brian J. Cuneo Ryan Sansom Nathan Ajiashvili Brandon Fenn Latham & Watkins LLP Cooley LLP 140 Scott Dr.

Website: https://investors.oysterpointrx.com/static-files/2733f13b-27c7-4532-9317-a009ba13e291

Category: Contact NumberShow more

Oyster Point Pharmaceuticals Crunchbase Company …

8 hours ago Crunchbase.com Get All

Contact Email [email protected] Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases.

Website: https://www.crunchbase.com/organization/oyster-point-pharmaceuticals

Category: Contact NumberShow more

Daniel Lochner Chief Financ.. Oyster Point Pharma

2 hours ago Zoominfo.com Get All

View Daniel Lochner's business profile as Chief Financial Officer at Oyster Point Pharma. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Daniel-Lochner/3245751485

Category: Contact NumberShow more

Matt Maguire Vice President Oyster Point Pharma

Just Now Zoominfo.com Get All

View Matt Maguire's business profile as Vice President at Oyster Point Pharma. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Matt-Maguire/5206826289

Category: Contact NumberShow more

Jill Andersen General Couns.. Oyster Point Pharma

1 hours ago Zoominfo.com Get All

View Jill Andersen's business profile as General Counsel & Chief Compliance Officer at Oyster Point Pharma. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Jill-Andersen/3888924237

Category: Contact NumberShow more

Jeffrey Nau President & Chi.. Oyster Point Pharma

8 hours ago Zoominfo.com Get All

View Jeffrey Nau's business profile as President & Chief Executive Officer at Oyster Point Pharma. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Jeffrey-Nau/936778717

Category: Contact NumberShow more

Pipeline Oyster Point Pharma

5 hours ago Oysterpointrx.com Get All

Oyster Point Pharma is committed to the discovery and development of first-in-class therapies to treat ophthalmic diseases. Leveraging our nicotinic acetylcholine receptor (nAChR) domain expertise, we are focused on the development of OC-01 (varenicline) nasal spray for the treatment of signs and symptoms of dry eye disease, as well as a number

Website: https://oysterpointrx.com/pipeline/

Category: Contact NumberShow more

FORM D SEC

4 hours ago Sec.gov Get All

(609) 382-9032

Oyster Point Pharma, Inc. Street Address 1 Street Address 2; 700 ALEXANDER PARK DRIVE: SUITE 301: City State/Province/Country ZIP/PostalCode Phone Number of Issuer; PRINCETON: NEW JERSEY: 08540 (609) 382-9032

Website: https://www.sec.gov/Archives/edgar/data/1720725/000172072519000002/xslFormDX01/primary_doc.xml

Category: Contact NumberShow more

Oyster Point Pharma, Inc. Home Facebook

9 hours ago Facebook.com Get All

Contact Oyster Point Pharma, Inc. on Messenger. oysterpointrx.com. Medical & Health. Page Transparency See More. Facebook is showing information to help you better understand the purpose of a Page. See actions taken by the people who manage and post content. Page created - …

Website: https://www.facebook.com/OysterPointRx/

Category: Home PhoneShow more

Our Focus Oyster Point Pharma

6 hours ago Oysterpointrx.com Get All

Disruption and instability of the tear film results in irritation, inflammation, and ultimately cellular damage. We believe that there is a significant unmet need for therapies that directly address the loss of tear film homeostasis, the fundamental characteristic of dry eye disease. Our lead product candidate OC-01 is designed to stimulate the

Website: https://oysterpointrx.com/our-focus/

Category: Contact NumberShow more

EIN 811030955 Oyster Point Pharma, Inc., Princeton, …

7 hours ago Eintaxid.com Get All

Oyster Point Pharma, Inc. is a corporation in Princeton, New jersey. The employer identification number (EIN) for Oyster Point Pharma, Inc. is 811030955. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Website: https://eintaxid.com/company/811030955-oyster-point-pharma%2C-inc./

Category: Contact NumberShow more

Michelle Beaty Senior Eye C.. Oyster Point Pharma

2 hours ago Zoominfo.com Get All

View Michelle Beaty's business profile as Senior Eye Care Territory Manager at Oyster Point Pharma. Find contact's direct phone number, email address, work history, and more.

Website: https://www.zoominfo.com/p/Michelle-Beaty/6194372973

Category: Contact NumberShow more

Board of Directors Oyster Point Pharma

6 hours ago Oysterpointrx.com Get All

Michael G. Atieh. Mike has served as a director and chairman of the Audit Committee of Immatics, N.V., a clinical-stage biopharmaceutical company, since July 2020. Mike has also served as director of electroCore, Inc., a medical technology company, since June 2018. He is currently Chairman and previously chaired the Audit Committee from June

Website: https://oysterpointrx.com/who-we-are/board-of-directors/

Category: Contact NumberShow more

Oyster Point Pharma IPOScoop

9 hours ago Iposcoop.com Get All

We are a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Our lead product candidate OC-01 (varenicline), a highly selective nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to

Website: https://www.iposcoop.com/ipo/oyster-point-pharma/

Category: Contact NumberShow more

Oyster Point Pharma, Inc. in Pierre, SD Company Info

7 hours ago Bizapedia.com Get All

Oyster Point Pharma, Inc. is a South Dakota Foreign business filed On February 25, 2021. The company's filing status is listed as Good standing and its File Number is FB197421. The Registered Agent on file for this company is C T Corporation System and is located at 319 S Coteau St, Pierre, SD 57501-3187.

Location: NJ

Website: https://www.bizapedia.com/sd/oyster-point-pharma-inc.html

Category: Contact NumberShow more

Oyster Point Pharma to Report Second Quarter 2021

5 hours ago Investors.oysterpointrx.com Get All

(855) 859-2056

To access the telephone replay, please dial (855) 859-2056 (US/Canada) or (404) 537-3406 (International). The conference ID number is 2278335. Webcast Details The webcast will be made available on the company’s website at www.oysterpointrx.com under the “Events & Presentations” section. About Oyster Point Pharma

Website: https://investors.oysterpointrx.com/news-releases/news-release-details/oyster-point-pharma-report-second-quarter-2021-financial-results

Category: Contact NumberShow more

Oyster Point Pharma (OYST) Company Profile & …

6 hours ago Stockanalysis.com Get All

Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ocular surface diseases in the United States. The company's lead product candidate is OC-01, a nicotinic acetylcholine receptor agonist that has completed Phase III clinical

Website: https://stockanalysis.com/stocks/oyst/company/

Category: Contact NumberShow more

Working at Oyster Point Pharma Glassdoor

8 hours ago Glassdoor.com Get All

Glassdoor gives you an inside look at what it's like to work at Oyster Point Pharma, including salaries, reviews, office photos, and more. This is the Oyster Point Pharma company profile. All content is posted anonymously by employees working at Oyster Point Pharma.

Website: https://www.glassdoor.com/Overview/Working-at-Oyster-Point-Pharma-EI_IE3106872.11,30.htm

Category: Contact NumberShow more

Oyster Point Pharma, Inc. (OYST) Company Profile & …

5 hours ago Finance.yahoo.com Get All

Oyster Point Pharma, Inc. was incorporated in 2015 and is headquartered in Princeton, New Jersey. Corporate Governance Oyster Point Pharma, Inc.’s ISS Governance QualityScore as of July 1, 2021

Website: https://finance.yahoo.com/quote/OYST/profile/

Category: Contact NumberShow more

Oyster Point Pharma Announces Preclinical Data

Just Now Investors.oysterpointrx.com Get All

Oyster Point Pharma plans to present data at the upcoming Analyst Day, scheduled for July 15, 2021 PRINCETON, N.J., July 01, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced preclinical data in non-human primates and in vitro models evaluating OC-01 (varenicline) nasal spray against SARS-CoV-2 and the alpha and

Website: https://investors.oysterpointrx.com/news-releases/news-release-details/oyster-point-pharma-announces-preclinical-data-highlighting

Category: Contact NumberShow more

Oyster Point Pharma, Inc. Stock Option Grant Notice …

5 hours ago Realdealdocs.com Get All

Oyster Point Pharma, Inc. (the “ Company ”), pursuant to its 2021 Inducement Plan (the “ Plan ”), has granted to you (“ Optionholder”) an option to purchase the number of shares of the Common Stock set forth below (the “ Option ”). Your Option is subject to all of the terms and conditions as set forth herein, and in the Plan, and the Stock Option Agreement and the Notice of

Website: https://www.realdealdocs.com/viewdocument.aspx?DocumentID=4133891

Category: Contact NumberShow more

Oyster Point Pharma Provides Key Supply Chain Insight …

Just Now Investors.oysterpointrx.com Get All

PRINCETON, N.J., June 29, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced information regarding a key supply chain insight for OC-01 (varenicline) nasal spray following the announcement that an unrelated manufacturer of varenicline oral tablets has suspended distribution due to impurities discovered in one or more lots of its product.

Website: https://investors.oysterpointrx.com/news-releases/news-release-details/oyster-point-pharma-provides-key-supply-chain-insight-oc-01

Category: Contact NumberShow more

OYST Oyster Point Pharma Inc. Stock Price & News …

3 hours ago Wsj.com Get All

News Oyster Point Pharma Inc.OYST. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings

Website: https://www.wsj.com/market-data/quotes/OYST

Category: Contact NumberShow more

Oyster Point Pharma Inc. (OYST): The long term …

5 hours ago Baxterreport.com Get All

The total number of common shares currently owned by the public is 25.99 million. OYST does have institutional investors; and they hold 89.20% of the stock. Oyster Point Pharma Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 10 new insider purchases involving 41,876 shares.

Website: https://baxterreport.com/2021/08/25/oyster-point-pharma-inc-oyst-the-long-term-indicators-on-the-stock-call-for-a-sell-today/

Category: Contact NumberShow more

Oyster Point Pharmaceuticals Employees, Board …

5 hours ago Crunchbase.com Get All

Oyster Point Pharmaceuticals has 7 current employee profiles, including Chairman Michael Ackermann. Oyster Point Pharmaceuticals has 6 board members and advisors, including Jeffrey Nau . …

Website: https://www.crunchbase.com/organization/oyster-point-pharmaceuticals/people

Category: Contact NumberShow more

Denali Contact

2 hours ago Denalitherapeutics.com Get All

©2020 Denali Therapeutics 161 Oyster Point Boulevard, South San Francisco, CA 94080

Website: https://www.denalitherapeutics.com/contact

Category: Contact SupportShow more

Oyster Point Pharma, Inc. (OYST) Stock Major Holders

4 hours ago Finance.yahoo.com Get All

Find out the direct holders, institutional holders and mutual fund holders for Oyster Point Pharma, Inc. (OYST).

Website: https://finance.yahoo.com/quote/oyst/holders

Category: Contact NumberShow more

Oncology Therapeutics Network Joint Venture, L.p. in …

8 hours ago Npino.com Get All

415-983-8619

The NPI Number for Oncology Therapeutics Network Joint Venture, L.p. is 1366620759. The current location address for Oncology Therapeutics Network Joint Venture, L.p. is 395 Oyster Point Blvd, #500, South San Francisco, California and the contact number is 415-983-8619 and fax number is …

Website: https://npino.com/pharmacy/1366620759-oncology-therapeutics-network-joint-venture,-l.p./

Category: Contact NumberShow more

Oyster Point Pharma, Inc. (OYST) 10K Annual Reports …

6 hours ago Last10k.com Get All

Inside Oyster Point Pharma, Inc.'s 10-K Annual Report: Financial - Expense Highlight These expenses consist primarily of: fees paid to third parties to conduct certain research and development activities on the Company's behalf and consulting costs; certain payroll-related expenses, including salaries and bonuses, employee benefit costs and stock-based compensation expense for …

Website: https://last10k.com/sec-filings/oyst

Category: Contact NumberShow more

Michael Ackermann Chairman @ Oyster Point

3 hours ago Crunchbase.com Get All

Overview. Michael is the founder of Oyster Point Pharma and currently serves as the Chairman of the Board. Michael is also developing two additional early-stage healthcare ventures. He was mostly recently Vice President, Neurostimulation for Allergan, plc after serving as CEO of Oculeve, Inc., which was acquired by Allergan in August 2015.

Website: https://www.crunchbase.com/person/d-michael-ackermann

Category: Contact NumberShow more

Contact Satsuma Pharmaceuticals

4 hours ago Satsumarx.com Get All

650.410.3200

Headquarters. Satsuma Pharmaceuticals, Inc. 400 Oyster Point Boulevard Suite 221 South San Francisco, CA 94080 Tel : 650.410.3200

Website: https://www.satsumarx.com/contact/

Category: Contact SupportShow more

Oyster Point Pharma, Inc. (OYST) Interactive Stock …

3 hours ago Finance.yahoo.com Get All

Oyster Point Pharma, Inc. (OYST) Q2 2021 Earnings Call Transcript. This evening, we issued a press release containing our second-quarter financial results and recent business highlights.

Website: https://finance.yahoo.com/quote/OYST/chart/

Category: Contact NumberShow more

EX99.2

4 hours ago Sec.gov Get All

Oyster Point Pharma plans to present data at the upcoming Analyst Day, scheduled for July 15, 2021 PRINCETON, N.J. , July 1, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), today announced preclinical data in non-human primates and in vitro models evaluating OC-01 (varenicline) nasal spray against SARS-CoV-2 and the alpha

Website: https://www.sec.gov/Archives/edgar/data/1720725/000119312521205491/d172758dex992.htm

Category: Contact NumberShow more

Oyster Point Pharma, Inc. 4 Sep. 1, 2021 6:00 PM …

9 hours ago Seekingalpha.com Get All

(Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code (Instr. 8) 5. …

Website: https://seekingalpha.com/filing/5694007

Category: Contact NumberShow more

Oyster Point Pharma, Inc. (OYST) Q2 2021 Earnings Call

9 hours ago Over50finance.com Get All

For the second quarter of 2021, Oyster Point Pharma reported a net loss of $22 million or $0.85 per share, compared to a net loss of $15.5 million or $0.66 per share for the same period in 2020. As of June 30, 2021, cash and cash equivalents were $154.8 million, compared to $192.6 million as of December 31, 2020.

Website: https://over50finance.com/2021/08/06/oyster-point-pharma-inc-oyst-q2-2021-earnings-call-transcript/

Category: Contact NumberShow more

Statement of Changes in Beneficial Ownership (4)

2 hours ago Ih.advfn.com Get All

Explanation of Responses: (1) The Option was granted on July 25, 2019 under the Oyster Point Pharma, Inc. 2016 Equity Incentive Plan. One quarter of the total number of shares subject to the option vested on July 22, 2020, and one forty-eighth of the remaining shares continue to vest monthly thereafter, subject to continued service to the Issuer through each such vesting date.

Website: https://ih.advfn.com/stock-market/NASDAQ/oyster-point-pharma-OYST/stock-news/85707624/statement-of-changes-in-beneficial-ownership-4

Category: Contact NumberShow more

Oyster Point Pharma, Inc. (OYST) Analyst Ratings

6 hours ago Finance.yahoo.com Get All

See Oyster Point Pharma, Inc. (OYST) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

Website: https://finance.yahoo.com/quote/OYST/analysis/

Category: Contact NumberShow more

Oyster Point Pharma, Inc., Reports Inducement Grants …

5 hours ago Marketscreener.com Get All

PRINCETON, N.J., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced that the Compensation Committee of its Board of Directors granted inducement non …

Website: https://www.marketscreener.com/quote/stock/OYSTER-POINT-PHARMA-INC-71598394/news/Oyster-Point-Pharma-Inc-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4-36303990/

Category: Contact NumberShow more

Oyster Point Pharma, Inc. (OYST) Income Statement …

8 hours ago Finance.yahoo.com Get All

Get the detailed quarterly/annual income statement for Oyster Point Pharma, Inc. (OYST). Find out the revenue, expenses and profit or loss over the last fiscal year.

Website: https://finance.yahoo.com/quote/OYST/financials/

Category: Contact NumberShow more

EDGAR Online

4 hours ago Content.edgar-online.com Get All

(609) 382-9032

202 Carnegie Center, Suite 109 . Princeton, New Jersey 08540 (609) 382-9032 (Address, including zip code, and telephone number, including area code, of Registrant’s principal ex

Website: https://content.edgar-online.com/ExternalLink/EDGAR/0001193125-19-262771.html?hash=64110d9fe21b12faa1a8d33d9fc2be08678c3e889a29662be7b1fd004a0998f2&dest=D637051DEX109_HTM

Category: Contact NumberShow more

Oyster Point Pharma Announces FDA Acceptance for …

2 hours ago Apnews.com Get All

PRINCETON, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases, today announced that the U.S. Food and Drug Administration (FDA) has

Website: https://apnews.com/press-release/globenewswire-mobile/entertainment-business-products-and-services-government-regulations-action-and-adventure-movies-762ee192dbd000d31bc577dc086b53ef

Category: Contact NumberShow more

OYST Stock Price Oyster Point Pharma Inc. Stock …

8 hours ago Marketwatch.com Get All

Oyster Point Pharma stock price target raised to $50 from $25 at J.P. Morgan Mar. 6, 2020 at 6:37 a.m. ET by Tomi Kilgore Oyster Point Pharma initiated at overweight with $26 price target at JP Morgan

Website: https://www.marketwatch.com/investing/stock/OYST

Category: Contact NumberShow more

Oyster Point Pharmaceuticals (OYST) Portfolio …

Just Now Versantventures.com Get All

Oyster Point is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapies to treat ocular surface disease.

Website: https://www.versantventures.com/portfolio/oyster-point-pharmaceuticals

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Popular Brands

Olam
Oracle
Orix
Okta
Oneok
Omv
Orpea
Orsted
Opera
Omron